Charles River Laboratories International (CRL) News Today $118.48 +1.19 (+1.01%) As of 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Aquatic Capital Management LLC Buys Shares of 24,195 Charles River Laboratories International, Inc. (NYSE:CRL)Aquatic Capital Management LLC purchased a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 24,195April 30 at 6:32 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 25.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 663,504 shares of the medical research company's stock after pApril 29 at 4:26 AM | marketbeat.comFirst Trust Advisors LP Buys 41,788 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)First Trust Advisors LP increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 56.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 115,483 shares of the medical research company's stock afApril 29 at 4:25 AM | marketbeat.comStifel Financial Corp Trims Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Stifel Financial Corp cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 10.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 90,055 shares of the medical research comApril 28 at 4:54 AM | marketbeat.comTower Research Capital LLC TRC Decreases Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Tower Research Capital LLC TRC decreased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 45.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,521 shares of the medApril 28 at 4:44 AM | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by Snyder Capital Management L PSnyder Capital Management L P grew its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 15.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 177,927 shares of the medical reApril 27 at 7:06 AM | marketbeat.comCanada Pension Plan Investment Board Takes Position in Charles River Laboratories International, Inc. (NYSE:CRL)Canada Pension Plan Investment Board purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 3,300 sApril 27 at 4:33 AM | marketbeat.comMarshall Wace LLP Decreases Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Marshall Wace LLP cut its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 93.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,608 shares of the medical researchApril 27 at 4:33 AM | marketbeat.comD1 Capital Partners L.P. Makes New $172.75 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL)D1 Capital Partners L.P. acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 935,820April 26, 2025 | marketbeat.comPinebridge Investments L.P. Has $20.79 Million Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Pinebridge Investments L.P. lowered its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 112,625 shares of the medical research company'sApril 26, 2025 | marketbeat.comJ. Safra Sarasin Holding AG Acquires Shares of 8,243 Charles River Laboratories International, Inc. (NYSE:CRL)J. Safra Sarasin Holding AG bought a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 8,243 shares of the medical research coApril 25, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Acquired by BI Asset Management Fondsmaeglerselskab A SBI Asset Management Fondsmaeglerselskab A S lifted its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 112.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,629 sharApril 25, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Receives Consensus Recommendation of "Reduce" from AnalystsCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) has been given a consensus recommendation of "Reduce" by the sixteen ratings firms that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and fiftApril 25, 2025 | marketbeat.comMesirow Institutional Investment Management Inc. Cuts Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Mesirow Institutional Investment Management Inc. lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 88.1% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,984 shares of the medical researApril 23, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Given Average Rating of "Reduce" by AnalystsApril 23, 2025 | americanbankingnews.comCharles River Laboratories International, Inc. (NYSE:CRL) Short Interest UpdateCharles River Laboratories International, Inc. (NYSE:CRL - Get Free Report) was the recipient of a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 2,660,000 shares, a decline of 19.4% from the March 15th total of 3,300,000 shares. Based on an average daily volume of 1,230,000 shares, the days-to-cover ratio is currently 2.2 days. Approximately 5.5% of the company's shares are sold short.April 22, 2025 | marketbeat.comUpslope Capital Management Sold Charles River (CRL) Due to Thesis BreakApril 22, 2025 | msn.comCharles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and DevelopmentApril 22, 2025 | businesswire.comKayne Anderson Rudnick Investment Management LLC Has $333.30 Million Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Kayne Anderson Rudnick Investment Management LLC lessened its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 6.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm ownApril 22, 2025 | marketbeat.comMeritage Group LP Trims Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Meritage Group LP reduced its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 9.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,074,120 shares of tApril 22, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Bought by Epoch Investment Partners Inc.Epoch Investment Partners Inc. increased its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 439.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 49,066 shares of the medical researchApril 22, 2025 | marketbeat.comXTX Topco Ltd Makes New Investment in Charles River Laboratories International, Inc. (NYSE:CRL)XTX Topco Ltd acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,921 shares of the medical research company's stocApril 22, 2025 | marketbeat.comBarclays PLC Sells 4,054 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Barclays PLC decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 3.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 126,772 shares of the medical research company's stock after selling 4,054 sApril 22, 2025 | marketbeat.comTownsquare Capital LLC Sells 8,154 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Townsquare Capital LLC reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 76.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,546 shares of the medical resApril 22, 2025 | marketbeat.comAldeyra Therapeutics: A Mispriced Gem With Reproxalap's CRL Creating A Golden Buying OpportunityApril 21, 2025 | seekingalpha.comJump Financial LLC Makes New $2.73 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL)Jump Financial LLC bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 14,794 shares of the medical research company'sApril 20, 2025 | marketbeat.comFederated Hermes Inc. Sells 42,039 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Federated Hermes Inc. lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 94.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 2,397 shares of the medical research company's stock after selling 42,039 shApril 20, 2025 | marketbeat.comCharles River Laboratories International, Inc. (CRL): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025April 19, 2025 | finance.yahoo.comTreasurer of the State of North Carolina Sells 17,654 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Treasurer of the State of North Carolina lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 44.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 22,456 shares ofApril 18, 2025 | marketbeat.com231,720 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Purchased by Raymond James Financial Inc.Raymond James Financial Inc. acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 231,720 sharesApril 18, 2025 | marketbeat.comCharles River price target raised to $118 from $101 at BairdApril 17, 2025 | markets.businessinsider.comThe 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?Amid market turbulence and policy shifts, do two of the S&P 500’s steepest decliners, DECK and CRL, offer deep value or signal deeper trouble ahead?April 16, 2025 | marketbeat.comBroyhill Asset Management Purchases Shares of 12,934 Charles River Laboratories International, Inc. (NYSE:CRL)Broyhill Asset Management purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 12,934 shares of the medical research company's stockApril 16, 2025 | marketbeat.comCapital Fund Management S.A. Boosts Stake in Charles River Laboratories International, Inc. (NYSE:CRL)Capital Fund Management S.A. raised its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 13.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 27,786 shares of the mediApril 16, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Russell Investments Group Ltd.Russell Investments Group Ltd. trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 29.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,445 sharesApril 16, 2025 | marketbeat.comCharles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference CallApril 15, 2025 | businesswire.com2,938 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Purchased by Qtron Investments LLCQtron Investments LLC purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund purchased 2,938 shares of the medical research company's stock, valued atApril 15, 2025 | marketbeat.comLegal & General Group Plc Sells 83,551 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)Legal & General Group Plc reduced its stake in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 26.0% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 237,879 shares of the medical research company's stock afterApril 15, 2025 | marketbeat.comCharles River price target lowered to $150 from $185 at BofAApril 15, 2025 | markets.businessinsider.comWhat is Zacks Research's Forecast for CRL Q2 Earnings?Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Research analysts at Zacks Research decreased their Q2 2026 EPS estimates for shares of Charles River Laboratories International in a research note issued on Thursday, April 10th. Zacks Research analyst R. Department now exApril 15, 2025 | marketbeat.comCharles River Laboratories International Inc (CRL) Shares Up 5.39% on Apr 14April 14, 2025 | gurufocus.comGrandeur Peak Global Advisors LLC Lowers Stock Position in Charles River Laboratories International, Inc. (NYSE:CRL)Grandeur Peak Global Advisors LLC lowered its position in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 40.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 30,055 shares of theApril 14, 2025 | marketbeat.comAPG Asset Management N.V. Acquires 22,349 Shares of Charles River Laboratories International, Inc. (NYSE:CRL)APG Asset Management N.V. lifted its holdings in Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 288.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor ownedApril 14, 2025 | marketbeat.comInvesco Ltd. Grows Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL)Invesco Ltd. grew its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 17.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,034,180 shares of the medicalApril 14, 2025 | marketbeat.comCharles River Laboratories International (NYSE:CRL) Sees Large Volume Increase - Here's What HappenedCharles River Laboratories International (NYSE:CRL) Sees Large Volume Increase - Time to Buy?April 13, 2025 | marketbeat.comZacks Research Brokers Decrease Earnings Estimates for CRLCharles River Laboratories International, Inc. (NYSE:CRL - Free Report) - Equities research analysts at Zacks Research dropped their Q1 2025 earnings per share estimates for Charles River Laboratories International in a research report issued on Thursday, April 10th. Zacks Research analyst R. DepApril 13, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Kennedy Capital Management LLCKennedy Capital Management LLC lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 21.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor oApril 13, 2025 | marketbeat.comCharles River Laboratories International, Inc. (NYSE:CRL) Stake Reduced by Envestnet Asset Management Inc.Envestnet Asset Management Inc. decreased its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 14.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor ownedApril 13, 2025 | marketbeat.comCharles River Gets Hit By The FDA, Too Early To Bet On A ComebackApril 12, 2025 | seekingalpha.comCharles River Laboratories International, Inc. (NYSE:CRL) Stock Holdings Boosted by Aviva PLCAviva PLC lifted its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL - Free Report) by 1,508.1% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 31,069 shares of the medical research company's stock after acquiring an additionalApril 12, 2025 | marketbeat.com Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address CRL Media Mentions By Week CRL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRL News Sentiment▼1.260.85▲Average Medical News Sentiment CRL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRL Articles This Week▼1310▲CRL Articles Average Week Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Mettler-Toledo International News Waters News Illumina News Bio-Techne News Bio-Rad Laboratories News Bruker News Pacific Biosciences of California News Harvard Bioscience News Thermo Fisher Scientific News Agilent Technologies News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CRL) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
